In the past, TLR2 ligands were shown to be promising adjuvants for allergy treatment in some studies (16–18), whereas other studies with mouse asthma models showed that TLR2 ligands could enhance proallergenic responses (40, 41). This evidence concerns the gene TLR2 and allergic disease.